Press Coverage, Opinion Arda Ozcubukcu 22/06/2023 Press Coverage, Opinion Arda Ozcubukcu 22/06/2023 Will the UK’s ambitious life sciences investment power-up the psychedelic sector? Read More Opinion Arda Ozcubukcu 27/10/2022 Opinion Arda Ozcubukcu 27/10/2022 Regulatory approval in under 8 weeks possible for psychedelic trials in the UK Read More Opinion Arda Ozcubukcu 22/11/2021 Opinion Arda Ozcubukcu 22/11/2021 Is the UK an ideal location to run psychedelic trials? Read More
Press Coverage, Opinion Arda Ozcubukcu 22/06/2023 Press Coverage, Opinion Arda Ozcubukcu 22/06/2023 Will the UK’s ambitious life sciences investment power-up the psychedelic sector? Read More
Opinion Arda Ozcubukcu 27/10/2022 Opinion Arda Ozcubukcu 27/10/2022 Regulatory approval in under 8 weeks possible for psychedelic trials in the UK Read More
Opinion Arda Ozcubukcu 22/11/2021 Opinion Arda Ozcubukcu 22/11/2021 Is the UK an ideal location to run psychedelic trials? Read More